VILINBIO

Vilin Bio Med Ltd.

42.60+2.0 (+4.80%)
27 Jul, 12:00 AM

Annual Reports and Financial Documents

Vilin Bio Med Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.
20232024
Annual Reports
Quarterly Results
Conference Calls
Presentations

Corporate Announcements and Regulatory Filings

Vilin Bio Med Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  • General Updates14 Jul 2026
    Vilin Bio Med Limited has informed the Exchange about General Updates
  • Updates10 Jul 2026
    Vilin Bio Med Limited has informed the Exchange regarding ''Non-applicability of Corporate Governance Regulations to the Company.
  • Certificate under SEBI (Depositories and Participants) Regulations, 20189 Jul 2026
    Vilin Bio Med Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
  • Outcome of Board Meeting27 Jun 2026
    VILINBIO: Vilin Bio Med Limited has informed the Exchange regarding Outcome of Board Meeting held on June 27, 2026.
  • Updates18 Jun 2026
    Vilin Bio Med Limited has informed the Exchange regarding ' Vilin Bio Med Limited has informed the Exchange regarding submission of Financial Results for the period ended March' 2026 in machine readable language.'.
  • Disclosure under SEBI Takeover Regulations17 Jun 2026
    Vilin Bio Med Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
  • Outcome of Board Meeting13 Jun 2026
    Vilin Bio Med Limited has informed the Exchange regarding Outcome of Board Meeting held on June 13, 2026.
  • Resignation11 Jun 2026
    Vilin Bio Med Limited has informed the Exchange regarding Resignation of Mr Avula Hariprasad as Chief Financial Officer of the Company w.e.f. Jun 11, 2026.
  • General Updates30 May 2026
    Vilin Bio Med Limited has informed the Exchange about General Updates
  • General Updates30 May 2026
    Vilin Bio Med Limited has informed the Exchange about General Updates
  • Outcome of Board Meeting30 May 2026
    Vilin Bio Med Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
  • Structural Digital Database29 May 2026
    VILINBIO: Vilin Bio Med Limited has provided the Compliance Certificate with respect to Structured Digital Database
  • General Updates18 May 2026
    Vilin Bio Med Limited has informed the Exchange about General Updates
  • General Updates13 Apr 2026
    Vilin Bio Med Limited has informed the Exchange about General Updates
  • Certificate under SEBI (Depositories and Participants) Regulations, 20189 Apr 2026
    Vilin Bio Med Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
  • Updates7 Apr 2026
    Vilin Bio Med Limited has informed the Exchange regarding 'Vilin Bio Med Limited has informed the Exchange regarding non-applicability of filing of Corporate Governance Report for the Quarter ended March 31, 2026.'.
  • Updates6 Apr 2026
    Vilin Bio Med Limited has informed the Exchange regarding 'Vilin Bio Med Limited has informed the Exchange regarding Annual Disclosure under Regulation 31(4) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulation, 2011.'.
  • General Updates30 Mar 2026
    Vilin Bio Med Limited has informed the Exchange about General Updates
  • Trading Window27 Mar 2026
    Vilin Bio Med Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
  • Outcome of Board Meeting4 Mar 2026
    VILINBIO: Vilin Bio Med Limited has informed the Exchange regarding the Outcome of Board Meeting held on March 04, 2026.

Frequently Asked Questions

Where can I download the annual report of Vilin Bio Med Ltd.?
Annual reports of Vilin Bio Med Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Vilin Bio Med Ltd.?
Quarterly earnings results and presentations of Vilin Bio Med Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Vilin Bio Med Ltd. publish earnings call transcripts?
Earnings call transcripts of Vilin Bio Med Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Vilin Bio Med Ltd.?
Investor presentations and annual day presentations of Vilin Bio Med Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Vilin Bio Med Ltd.?
Corporate announcements and regulatory filings of Vilin Bio Med Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Vilin Bio Med Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Vilin Bio Med Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Vilin Bio Med Ltd.?
The ISIN (International Securities Identification Number) of Vilin Bio Med Ltd. is INE0L4V01013. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Vilin Bio Med Ltd. listed?
Vilin Bio Med Ltd. is listed on NSE and BSE. The NSE symbol is VILINBIO and the BSE code is -.
Where can I find the shareholding pattern of Vilin Bio Med Ltd.?
The quarterly shareholding pattern of Vilin Bio Med Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Vilin Bio Med Ltd. on Sharpely?
Share price data for Vilin Bio Med Ltd. is updated as of 27 Jul 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.